mHealth App Intervention to Improve Medication Adherence

NCT04577157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2022-03-17

No results posted yet for this study

Summary

It is a parallel-design, two-arm, randomized controlled trial designed to assess the effectiveness of mHealth application using 7- items, multifaceted educational and reminder module intervention( written message, voice message, multimedia picture, Graphic based Messages(GBM), video, hypertension at a glance, and doctor support) to improve adherence to medication in hypertensive patients and clinical outcome systolic blood pressure in Lahore, Pakistan. Cost-effectiveness of this study will also be done.

Conditions

  • Medication Adherence
  • Adherence, Treatment

Interventions

BEHAVIORAL

mHealth using"WhatsApp" multifaceted educational and reminder module intervention to improve adherence

This multifaceted educational and reminder module is named "Health@click". The content of the reminder module has been made based on "The Health Belief Model and self-determination theory. 1. Daily notes for medication reminders, 2. Daily a voice message with the same content will be delivered. 3. Daily Graphics-based Reminder (GBR). 4. Twice-weekly Graphics-based Messages (GBM) according to Health believe model and Self-determination theory constituents. 5. Once-weekly lifestyle advice through video 6. Hypertension at a glance, complete information will be provided(Optional) 7. 24/7 help provision service will be given to the participants. A qualified doctor will be there to provide this educational support. Support will be including the dose of medicine, frequency, mode of action, effects of medicine on current illness, side effects, and interaction with different foods (Optional).

Sponsors & Collaborators

  • Universiti Putra Malaysia

    lead OTHER

Principal Investigators

  • Mehwish Kiran, MBBS · Doctors Hospital, Lahore

  • Arshed Muhammad, MBBS · UPM

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-03
Primary Completion
2021-11-06
Completion
2021-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04577157 on ClinicalTrials.gov